Literature DB >> 1101923

The natural history of non-Hodgkin's lymphomata stages I and II.

L M Fuller, F L Banker, J J Butler, J F Gamble, M P Sullivan.   

Abstract

Progress in the management of non-Hodgkin's lymphomata has been impeded by lack of information on the natural history of these diseases. Confusion about the significance of histopathology, extranodal presentations and routes of spread renders much of previously published data relatively uninterpretable. To evaluate the relative prognostic significance of presentation, histopathology and lymphography, a retrospective study was undertaken on 226 patients with Stage I and II disease, who were treated with intensive irradiation to the involve regions. The slides on these patients were reviewed and reclassified in terms of the Rappaport system. The results of this study demonstrated that a nodular histopathological pattern was the most important prognostic factor. The significance of this finding and other factors are discussed in terms of possible new approaches to treatment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1101923      PMCID: PMC2149560     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  7 in total

1.  A clinicopathological study of stages I and II non-Hodgkin's lymphomata using the Lukes-Collins classification.

Authors:  J J Butler; J A Stryker; C C Shullenberger
Journal:  Br J Cancer Suppl       Date:  1975-03

2.  Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases.

Authors:  E B HICKS; H RAPPAPORT; W J WINTER
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

3.  Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases.

Authors:  S E Jones; Z Fuks; M Bull; M E Kadin; R F Dorfman; H S Kaplan; S A Rosenberg; H Kim
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

4.  Chemotherapy of malignant lymphoma with adriamycin.

Authors:  J A Gottlieb; J U Gutterman; K B McCredie; V Rodriguez; E Frei
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

5.  Results of large volume irradiation in the management of Hodgkin's disease and malignant lymphomas originating in the abdomen.

Authors:  L M Fuller
Journal:  Radiology       Date:  1966-12       Impact factor: 11.105

6.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

7.  Estimating survival functions from the life table.

Authors:  E A Gehan
Journal:  J Chronic Dis       Date:  1969-02
  7 in total
  4 in total

1.  A clinicopathological study of stages I and II non-Hodgkin's lymphomata using the Lukes-Collins classification.

Authors:  J J Butler; J A Stryker; C C Shullenberger
Journal:  Br J Cancer Suppl       Date:  1975-03

2.  A randomized trial of two types of adjuvant chemotherapy in radiotherapy-treated patients with clinical stages I and II high-grade non-Hodgkin's lymphoma.

Authors:  J Wagstaff; I Todd; D Deakin; P Wilkinson; J H Scarffe; M Harris; M Jones; D Crowther
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Primary lymphoma of the penis with rationale of treatment.

Authors:  R D Carter; R Smith; H D Alpern; B M Healey
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

4.  Model-based meta-analysis of individual International Prostate Symptom Score trajectories in patients with benign prostatic hyperplasia with moderate or severe symptoms.

Authors:  Salvatore D'Agate; Timothy Wilson; Burkay Adalig; Michael Manyak; Juan Manuel Palacios-Moreno; Chandrashekhar Chavan; Matthias Oelke; Claus Roehrborn; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2020-04-14       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.